Sentinus LLC’s DexCom DXCM Stock Holding History

Sentinus LLC’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$255K	Buy	3,792 +434	+13%	+$28.9K	0.02%	522
2026 Q1	$211K	Buy	+3,358	New	+$234K	0.02%	540

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Sentinus LLC's DXCM Position: Q2 2026 in Review

Sentinus LLC increased its DexCom (DXCM) stake by 13% in Q2 2026, buying an estimated $28.9K and bringing the position to 3,792 shares worth $255K. The position accounts for 0.02% of the portfolio, ranked #522.

Sentinus LLC first reported a position in DXCM in Q1 2026 and has held it in 2 quarters since. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Sentinus LLC held 3,792 shares of DexCom worth $255K as of Q2 2026.
Sentinus LLC bought 434 DexCom shares in Q2 2026, an estimated $28.9K.
DexCom made up 0.02% of Sentinus LLC's portfolio in Q2 2026, its #522 holding.
Sentinus LLC first reported a position in DexCom in Q1 2026 and has held it in 2 quarters since.
974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Sentinus LLC's 13F filing for Q2 2026, filed 11 Aug 2026.